Targeting Hidden Pathogens: Cell-Penetrating Enzybiotics Eradicate Intracellular Drug-Resistant Staphylococcus aureus

Authors:
Open Access
Publisher website
Google Scholar
Abstract
The increasing prevalence of antibiotic-resistant bacteria is one of the most urgent problems of our time. Staphylococcus aureus is an important human pathogen that has acquired several mechanisms to evade antibiotic treatment. In addition, S. aureus is able to invade and persist within human cells, hiding from the immune response and antibiotic therapies. For these reasons, novel antibacterial strategies against these pathogens are needed. Here, we developed lytic enzymes which are able to effectively target drug-resistant and intracellular S. aureus . Fusion of these so-called enzybiotics to cell-penetrating peptides enhanced their uptake and intracellular bactericidal activity in cell culture and in an abscess mouse model. Our results suggest that cell-penetrating enzybiotics are a promising new class of therapeutics against staphylococcal infections.
Funding Information
  • ETH Zurich (ETH-11 14-2)
  • Swiss National Science Foundation (407240_167037)
  • Swiss National Science Foundation (310030_146295)
  • Swiss National Science Foundation (31003A_176252)
  • Micreos BV (N/A)
  • Mahidol University (N/A)

This publication has 78 references indexed in Scilit: